AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the
Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck
Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data.
BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug
Greater availability of African genomic data could lead to medical breakthroughs for the continent’s 1.2 billion people. That’s the driving proposition of 54gene —
With shortages of N95 face masks persisting nationwide, healthcare facilities are scrambling to find ways to clean and treat the masks for reuse to
“I want to build a business which profiles every single researcher and healthcare professional in the world and I want to sell it to